Search results
Results From The WOW.Com Content Network
The Strong Heart Study was the first research funded by the NHLBI focusing on specific ethnic groups in rural communities. [11] The 13 American Indian communities were involved in partnership with investigators in all aspects of the study design to ensure the recruitment of participants and conduct of examinations was culturally appropriate and ...
The National Heart, Lung, and Blood Institute (NHLBI) is the third largest Institute of the National Institutes of Health, located in Bethesda, Maryland, United States.It is tasked with allocating about $3.6 billion in FY 2020 [1] in tax revenue to advancing the understanding of the following issues: development and progression of disease, diagnosis of disease, treatment of disease, disease ...
The Multi-Ethnic Study of Atherosclerosis (abbreviated MESA) is an ongoing medical study which aims to investigate the characteristics of subclinical atherosclerosis and other cardiovascular diseases, and to determine risk factors for its progression to the clinically overt form of these diseases. [1]
Research on how environmental exposures, genetic susceptibility, and age interact to affect an individual's health. 1969 $675.8 niehs.nih.gov: National Institute on Alcohol Abuse and Alcoholism: NIAAA NIAAA research is focused on improving the treatment and prevention of alcoholism and alcohol-related problems. 1970 $456.0 niaaa.nih.gov
Framingham Heart Study physicians. The Framingham Heart Study is a long-term, ongoing cardiovascular cohort study of residents of the city of Framingham, Massachusetts.The study began in 1948 with 5,209 adult subjects from Framingham, and is now on its third generation of participants. [1]
As of 2013, the IRP had 1,200 principal investigators and more than 4,000 postdoctoral fellows in basic, translational, and clinical research, being the largest biomedical research institution in the world, [1] while, as of 2003, the extramural arm provided 28% of biomedical research funding spent annually in the U.S., or about US$26.4 billion.
Cardiovascular Cell Therapy Research Network (CCTRN) is a network of physicians, scientists, and support staff dedicated to studying stem cell therapy for treating heart disease. The CCTRN is funded by the National Institutes of Health (NIH) and includes expert researchers with experience in cardiovascular care at seven stem cell centers in the ...
The Framingham Risk Score is a sex-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. The Framingham Risk Score was first developed based on data obtained from the Framingham Heart Study, to estimate the 10-year risk of developing coronary heart disease. [1]